Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Strategic Partnership with Madison Partners


Posted on: 21 Mar 18

JERSEY CITY, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a strategic partnership and confidential BTC Lending Program Participation Agreement with Madison Partners LLC, a market-leading liquidity provider for trade execution in digital assets and cryptocurrency worldwide.

Initially, Yield Endurance borrowed the $5 million in Bitcoin delivered to Madison Partners for loans to market participants from a single source. In the future, Yield Endurance intends to seek out other lending sources of cryptocurrencies to provide lending capital to Madison Partners. Madison Partners will provide borrowers with direct access to cryptocurrency inventory and will leverage its expertise in cryptocurrency trading and strong client relationships to generate return on the loans, which will be shared between both parties.

David Lelong, Chief Executive Officer of Sport Endurance and Yield Endurance, stated, “We are pleased to enter into our first strategic partnership with Madison Partners and achieve this signification milestone in our cryptocurrency lending business strategy. Our operational expertise and access to cryptocurrency inventory is complimentary to Madison Partners’ proprietary trading and execution expertise and technology. Together, our goal is to alleviate many of the trading inefficiencies that institutional investors face in cryptocurrency investing. Our platform will provide an outlet for more efficient trading and a steady rate of return within this asset class.”

About Madison Partners
Madison Partners is a registered Money Services Business focused on providing counter parties with over the counter liquidity and block trading services.

About Sport Endurance, Inc. and Wholly-Owned Subsidiary, Yield Endurance, Inc.
Sport Endurance develops, markets, and distributes nutritional supplement products throughout the United States. Through its wholly-owned subsidiary, Yield Endurance, it is hoping to increase liquidity and institutional participation in the cryptocurrency markets by providing institutional investors the ability to borrow, hedge, and arbitrage cryptocurrencies that trade on the various cryptocurrency exchanges including Bitcoin, Bitcoin Cash, Ethereum and Litecoin. In doing so, the Company is facilitating the ability of institutional investors to participate in the fixed income opportunity of cryptocurrency lending. Through the Company’s cryptocurrency lending program operated by its partner, institutional investors will have the ability to better manage cryptocurrency risk and increase yield to maximize return on investment for their funds. Yield Endurance’s cryptocurrency lending program is a diversified lending vehicle for institutional investors who are looking for managed exposure to the cryptocurrency market. For more information, please visit http://www.sportenduranceinc.com and http://www.yieldendurance.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements relating to the Bitcoin program and anticipated fees. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.  Some or all of the results anticipated by these forward-looking statements may not be achieved, Important factors that could cause actual results to differ from those in the forward-looking statements include the Company's need for capital, the future condition of the capital markets in general and the market for microcap securities, and regulatory and other developments in the markets for cryptocurrency including substantial price declines. Investors should carefully review the risk factors in the Form 8-K filed with the Securities and Exchange Commission on March 14, 2018. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT: Company Contact: Sport Endurance, Inc. David Lelong, President and CEO 646-846-4280 Investor Contact: KCSA Strategic Communications Valter Pinto, Managing Director 212.896.1254 Valter@KCSA.com  www.KCSA.comGlobeNewswire
globenewswire.com

Last updated on: 22/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.